Kardi Ai has raised €5.3m in Series A funding to expand its AI-powered heart monitoring technology and develop models to assess the risk of cardiac arrhythmias.
🔗 Full story: buff.ly/oE7ayYU
#KardiAi #CardiacMonitoring #Medtech #DigitalHealth #HealthTechInvestment
11
Oyster Therapeutics has raised US$60m in Series A-2 funding to advance an experimental oral Alzheimer's drug towards clinical development.
🔗 Full story: buff.ly/FbZe5BE
#AlzheimersDisease #OysterTherapeutics #DrugDevelopment #Biotechnology #HealthcareInvestment
14
Annovis Bio has closed a US$21m public offering, with proceeds expected to fund operations through a pivotal Alzheimer's trial readout in March 2027.
🔗 Full story: buff.ly/GZfca0C
#AnnovisBio #AlzheimersDisease #ParkinsonsDisease #Biotechnology #HealthcareInvestment
18
US researchers have secured a US$3.4m grant to develop AI tools to detect delirium earlier and predict its onset in older hospital patients.
🔗 Full story: buff.ly/yAwDN5t
#Delirium #ArtificialIntelligence #BrainHealth #AlzheimersResearch #HealthyAgeing
15
A £20m dementia research hub will develop AI and data systems for ten new NHS brain health clinics, aiming to improve early detection, diagnosis and prevention.
🔗 Full story: buff.ly/JZYHuif
#DementiaResearch #BrainHealth #ArtificialIntelligence #NHS #HealthyAgeing
11
Circular Genomics and PharmatrophiX have agreed to study Alzheimer’s blood biomarkers to investigate how patients respond to an experimental treatment.
🔗 Full story: buff.ly/Zt5Zlie
#AlzheimersDisease #Biomarkers #PrecisionMedicine #Biotechnology #DementiaResearch
19
A new medication risk tool could help doctors and pharmacists identify older patients at risk of falls and delirium linked to multiple anticholinergic medicines.
🔗 Full story: buff.ly/ZtV9sDQ
#MedicationSafety #HealthyAgeing #FallsPrevention #Delirium #HealthTech
Novartis has terminated its BioArctic brain-delivery deal, worth up to US$802m, ending the prospect of US$772m in additional payments.
🔗 Full story: buff.ly/p3l1QZG
#Novartis #BioArctic #Biotechnology #DrugDevelopment #BrainHealth
35
A charity-funded study will analyse 80,000 blood samples for early biological signs of Alzheimer’s, Parkinson’s and other neurodegenerative conditions.
🔗 Full story: buff.ly/o8Eg1GI
#AlzheimersResearch #ParkinsonsDisease #BrainHealth #DementiaResearch #Biomarkers
11
Specific Biologics has closed an oversubscribed US$35m Series A round to advance an experimental gene-editing treatment for a genetic form of ALS.
🔗 Full story: buff.ly/kIoqFZw
#ALS #GeneEditing #Biotechnology #LifeSciences #HealthcareInvestment
37
StimCardio Medical has raised US$30m to advance a wearable therapy aimed at reducing recurrent atrial fibrillation following catheter ablation.
🔗 Full story: buff.ly/3HYzGtC
#StimCardio #AtrialFibrillation #WearableTechnology #Medtech #HealthcareInvestment
19
The global longevity biotech market is forecast to exceed US$31bn by 2030, growing by around 8 per cent annually, according to a new report.
🔗 Full story: buff.ly/hie9ZCd
#Longevity #Biotechnology #HealthyAgeing #RegenerativeMedicine #LongevityMarket
13
A five-year, €13m European project has launched to support Phase I and II clinical development of EXO-101, an experimental osteoarthritis treatment.
🔗 Full story: buff.ly/zymyiDX
#Osteoarthritis #Biotechnology #DrugDevelopment #RegenerativeMedicine #HealthResearch
18
Kivo Health has raised US$10m in Series A funding to expand its AI-powered virtual care programme for people managing chronic disease.
🔗 Full story: buff.ly/HGfzauT
#KivoHealth #AgeTech #ChronicDisease #VirtualCare #HealthcareInvestment
11
Italian startup Magic Vision has raised €600,000, helping it bring an AI monitoring system for older and vulnerable people to market.
🔗 Full story: buff.ly/msUEZPK
#MagicVision #AgeTech #ArtificialIntelligence #ElderlyCare #CareTechnology
12
MedEnvision has agreed a majority-stake private equity deal to support the international expansion of its surgical technology business.
🔗 Full story: buff.ly/AqIJbE6
#MedEnvision #Medtech #OrthopaedicSurgery #PrivateEquity #HealthcareInvestment
17
An ADHD drug will be tested alongside a diabetes medicine in a UK Alzheimer's trial designed to more than halve the time needed to assess treatments.
🔗 Full story: buff.ly/n8HTQWI
#AlzheimersResearch #DementiaResearch #ClinicalTrials #DrugDevelopment #DementiaCare
16
Anaconda Biomed has raised €48.9m (US$56m) to complete a clinical study of its stroke clot-removal device and support development of new devices.
🔗 Full story: buff.ly/OJwXBhp
#StrokeTreatment #Medtech #HealthcareInvestment #MedicalInnovation #StrokeRecovery
6
Diabetes may mask biological changes linked to Alzheimer's disease in the brain, potentially complicating research into the condition, a study suggests.
🔗 Full story: buff.ly/Mt2rq8y
#AlzheimersResearch #Diabetes #DementiaResearch #BrainHealth #HealthyAgeing
Johns Hopkins University has secured US$20m over five years to develop AI and other technologies for Alzheimer's disease and ageing care.
🔗 Full story: buff.ly/klhDOo8
#AlzheimersResearch #ArtificialIntelligence #DementiaCare #AgeTech #HealthyAgeing
12




















